Difference between revisions of "Part:BBa K4165085"
Ahmedsameh (Talk | contribs) |
Omnia Alaa11 (Talk | contribs) |
||
(5 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
This basic part encodes Human serine protease inhibitor known as SPINK14 which is able to inhibit trypsin-like proteases, like HtrA1 (BBa_K4165004). | This basic part encodes Human serine protease inhibitor known as SPINK14 which is able to inhibit trypsin-like proteases, like HtrA1 (BBa_K4165004). | ||
− | |||
− | |||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | This type of family encodes for a type of inhibitor that is predicted to be able to inhibit serine peptidases. The inhibitor is present extracellularly. The inhibitor binds to trypsin-like proteases (serine proteases) and since the catalytic core of HtrA1 (BBa_K4165004) is considered as a trypsin-like catalytic domain, so this inhibitor also is considered to inhibit the function of HtrA1 [1 | + | This type of family encodes for a type of inhibitor that is predicted to be able to inhibit serine peptidases. The inhibitor is present extracellularly. The inhibitor binds to trypsin-like proteases (serine proteases) and since the catalytic core of HtrA1 (BBa_K4165004) is considered as a trypsin-like catalytic domain, so this inhibitor also is considered to inhibit the function of HtrA1 <sup>[1-3]</sup>. |
<!-- --> | <!-- --> | ||
− | <span class='h3bb'>Sequence and Features</span> | + | ===<span class='h3bb'>Sequence and Features</span>=== |
<partinfo>BBa_K4165085 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165085 SequenceAndFeatures</partinfo> | ||
− | === | + | ===Dry-Lab Characterization=== |
− | + | ||
− | + | ||
− | + | <p style=" font-weight: bold; font-size:14px;"> Modelling </p> | |
− | + | ||
− | + | This inhibitor was modeled by several software and the top model was acquired by Alphafold | |
− | + | ||
− | + | <p style=" font-weight: bold; font-size:14px;"> Quality Assessment </p> | |
− | + | ||
− | = | + | <html> |
+ | <style> | ||
+ | table, th, td { | ||
+ | border:1px solid black; margin-left:auto;margin-right:auto; | ||
+ | } | ||
+ | </style> | ||
+ | <body> | ||
+ | <table style="width:65%"> | ||
+ | <table> | ||
+ | <tr> | ||
+ | <th>cbeta_deviations</th> | ||
+ | <th>clashscore</th> | ||
+ | <th>molprobity</th> | ||
+ | <th>ramachandran_favored</th> | ||
+ | <th>ramachandran_outliers</th> | ||
+ | <th>Qmean_4</th> | ||
+ | <th>Qmean_6</th> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>0</td> | ||
+ | <td>50.77</td> | ||
+ | <td>3.2</td> | ||
+ | <td>78.95</td> | ||
+ | <td>8.42</td> | ||
+ | <td>-3.71517</td> | ||
+ | <td>-3.3123</td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | </body> | ||
+ | </html> | ||
− | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-inhibitors/model4-alphafold.png" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
− | + | Figure 1.: A graphical illustration showing the structure of the inhibitor (Model 4-AlphaFold). | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
+ | <p style=" font-weight: bold; font-size:14px;"> Docking </p> | ||
− | + | <p> ΔG = -37.794 </p> | |
− | <p> | + | |
− | + | ||
− | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-inhibitors/dry-lab/dock-q6ie38.png" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
+ | Figure 2.: A graphical illustration showing the binding of the inhibitor with HtrA1 (Galaxy). | ||
− | ===Reference=== | + | ===Reference:=== |
− | 1 - Frochaux, V., Hildebrand, D., Talke, A., Linscheid, M. W., & Schlüter, H. (2014). Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue. PloS one, 9(10), e109483. | + | 1 - Frochaux, V., Hildebrand, D., Talke, A., Linscheid, M. W., & Schlüter, H. (2014). Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue. PloS one, 9(10), e109483. <br> |
− | 2 - Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026. | + | 2 - Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.<br> |
− | 3 - Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050. | + | 3 - Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.<br> |
<partinfo>BBa_K4165085 parameters</partinfo> | <partinfo>BBa_K4165085 parameters</partinfo> | ||
<!-- --> | <!-- --> |
Latest revision as of 12:36, 13 October 2022
SPINK14 (Serine Peptidase Inhibitor Kazal type 14).
This basic part encodes Human serine protease inhibitor known as SPINK14 which is able to inhibit trypsin-like proteases, like HtrA1 (BBa_K4165004).
Usage and Biology
This type of family encodes for a type of inhibitor that is predicted to be able to inhibit serine peptidases. The inhibitor is present extracellularly. The inhibitor binds to trypsin-like proteases (serine proteases) and since the catalytic core of HtrA1 (BBa_K4165004) is considered as a trypsin-like catalytic domain, so this inhibitor also is considered to inhibit the function of HtrA1 [1-3].
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry-Lab Characterization
Modelling
This inhibitor was modeled by several software and the top model was acquired by Alphafold
Quality Assessment
cbeta_deviations | clashscore | molprobity | ramachandran_favored | ramachandran_outliers | Qmean_4 | Qmean_6 |
---|---|---|---|---|---|---|
0 | 50.77 | 3.2 | 78.95 | 8.42 | -3.71517 | -3.3123 |
Figure 1.: A graphical illustration showing the structure of the inhibitor (Model 4-AlphaFold).
Docking
ΔG = -37.794
Figure 2.: A graphical illustration showing the binding of the inhibitor with HtrA1 (Galaxy).
Reference:
1 - Frochaux, V., Hildebrand, D., Talke, A., Linscheid, M. W., & Schlüter, H. (2014). Alpha-1-antitrypsin: a novel human high temperature requirement protease A1 (HTRA1) substrate in human placental tissue. PloS one, 9(10), e109483.
2 - Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.
3 - Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.